Cargando…
Quantum-dot-labeled synuclein seed assay identifies drugs modulating the experimental prion-like transmission
Synucleinopathies are neurodegenerative disorders including Parkinson disease (PD), dementia with Lewy body (DLB), and multiple system atrophy (MSA) that involve deposits of the protein alpha-synuclein (α-syn) in the brain. The inoculation of α-syn aggregates derived from synucleinopathy or preforme...
Autores principales: | Imamura, Yukio, Okuzumi, Ayami, Yoshinaga, Saki, Hiyama, Akiko, Furukawa, Yoshiaki, Miyasaka, Tomohiro, Hattori, Nobutaka, Nukina, Nobuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243017/ https://www.ncbi.nlm.nih.gov/pubmed/35768587 http://dx.doi.org/10.1038/s42003-022-03590-8 |
Ejemplares similares
-
Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment
por: Okuzumi, Ayami, et al.
Publicado: (2018) -
Propagative α-synuclein seeds as serum biomarkers for synucleinopathies
por: Okuzumi, Ayami, et al.
Publicado: (2023) -
α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property
por: Daida, Kensuke, et al.
Publicado: (2022) -
Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy
por: Katorcha, Elizaveta, et al.
Publicado: (2017) -
Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation
por: Oueslati, Abid, et al.
Publicado: (2014)